4//SEC Filing
Shanmugam Muthusamy 4
Accession 0001870913-25-000008
CIK 0001023024other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 6:10 PM ET
Size
8.5 KB
Accession
0001870913-25-000008
Insider Transaction Report
Form 4
Shanmugam Muthusamy
DirectorHEAD OF R&D, COO-NOVITIUM OPS
Transactions
- Sale
Common Stock
2025-08-20$90.27/sh−47,012$4,243,773→ 484,908 total(indirect: By LLC) - Sale
Common Stock
2025-08-21$90.44/sh−52,988$4,792,235→ 431,920 total(indirect: By LLC)
Holdings
- 92,588
Common Stock
- 5,000(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]The shares were sold in multiple trades at prices ranging from $89.21 to $90.83. The price reported above reflects the weighted average sales price.
- [F2]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F3]The shares were sold in multiple trades at prices ranging from $89.90 to $91.44. The price reported above reflects the weighted average sales price.
- [F4]The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001870913
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 6:10 PM ET
- Size
- 8.5 KB